The Only FDA Cleared Wearable Device for 24/7 Chronic Pain Relief Without a Prescription WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology will be exhibited at NY16 - Podiatric Clinical Conference and Exhibition sponsored
The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology will be featured at the North Carolina Foot & Ankle Society's Winter Scientific Seminar to be held January 28-31
The Only FDA Cleared Wearable for 24/7 Chronic Pain Relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology will be featured at the APMA Annual Meeting this week in Orlando, Florida .
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable Pain Relief Technology will be featured at the PAINWeek 2015 National Conference this week in Las Vegas, Nevada . PAINWeek is the nation's largest pain conference for frontline clinicians with an
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable Pain Relief Technology will be exhibited at the Pri-Med East Annual Conference in Boston on September 18-20, 2015 . The Pri-Med East Annual Conference curriculum is developed with the American College
WOBURN, Mass. , June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that a CE (Conformité Européenne ) Technical File Application for Quell ® has been submitted to TŰV SŰD Product Service GmbH, which is one of the Notified Bodies responsible for reviewing and approving new
Early Filing Achieved with Omron Healthcare China WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep
Close collaboration with Omron Healthcare in preparation of the Filing WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, reported the regulatory submission for NC-stat
WALTHAM, Mass. --(BUSINESS WIRE)-- In recognition of Pain Awareness Month this September, NeuroMetrix, Inc. (Nasdaq: NURO) is partnering with the U.S. Pain Foundation , a nonprofit organization dedicated to serving those who live with pain conditions and their providers, to raise awareness of the
